The effect of phosphodiesterase III inhibitors on human neutrophil function

Katsuya Mikawa, Hirohiko Akamatsu, Kahoru Nishina, Makoto Shiga, Nobuhiro Maekawa, Hidefumi Obara, Yukie Niwa

研究成果: Article査読

19 被引用数 (Scopus)

抄録

Objectives: Neutrophils play an important role in ridding the body of bacteria and cellular debris. Several neutrophil functions are thought to be regulated by inotropes that increase cellular levels of cyclic adenosine monophosphate, including phosphodiesterase (PDE) inhibitors. We have investigated the effect of amrinone, milrinone, and olprinone, type III PDE (PDE-III) inhibitors, on several human neutrophil functions. Design: Prospective in vitro study. Setting: Academic research laboratory. Subjects: Neutrophils isolated from 12 healthy adult volunteers. Interventions: We measured chemotaxis, phagocytosis, reactive oxygen species production, intracellular calcium ion concentration, and cyclic adenosine monophosphate levels in neutrophils in the absence and the presence (at clinically relevant concentrations, 10 times, and 100 times those concentrations) of amrinone, milrinone, or olprinone. We also measured reactive oxygen species production under the same condition in a xanthine-xanthine oxidase system. Measurements and Main Results: None of the PDE-III inhibitors impaired neutrophil chemotaxis or phagocytosis. Amrinone at clinically relevant or higher concentrations and milrinone at high concentrations reduced superoxide, hydrogen peroxide, and hydroxyl radical levels in neutrophils and in the xanthine-xanthine oxidase system. Olprinone did not have those effects, and none of the PDE-III inhibitors had an effect on intracellular calcium ion concentration or cyclic adenosine monophosphate production in neutrophils stimulated by a chemotactic factor. Conclusions: The ability of amrinone to scavenge reactive oxygen species st clinically relevant concentrations while not affecting neutrophil function suggests that the PDE inhibitor can be used without detriment in severely ill patients.

本文言語English
ページ(範囲)1001-1005
ページ数5
ジャーナルCritical Care Medicine
28
4
DOI
出版ステータスPublished - 01-01-2000
外部発表はい

All Science Journal Classification (ASJC) codes

  • Critical Care and Intensive Care Medicine

フィンガープリント 「The effect of phosphodiesterase III inhibitors on human neutrophil function」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。

引用スタイル